Publicaciones en colaboración con investigadores/as de Institut d'Investigació Biomèdica Girona (20)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder

    Drug and Alcohol Dependence, Vol. 245

  3. TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck

    Frontiers in Oncology, Vol. 13

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2019

  1. Capacity adiposity indices to identify metabolic syndrome in subjects with intermediate cardiovascular risk (MARK study)

    PLoS ONE, Vol. 14, Núm. 1

  2. Hypertension and high ankle brachial index: The overlooked combination

    Journal of Hypertension, Vol. 37, Núm. 1, pp. 92-98

  3. Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

    Aging, Vol. 11, Núm. 9, pp. 2874-2888

  4. Neoadjuvant metformin added to systemic therapy decreases the proliferative capacity of residual breast cancer

    Journal of Clinical Medicine, Vol. 8, Núm. 12

  5. Reclassification by applying the Framingham equation 30 years to subjects with intermediate cardiovascular risk. MARK study

    Medicina Clinica, Vol. 153, Núm. 9, pp. 351-356

  6. The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin

    Frontiers in Oncology, Vol. 9, Núm. MAR

2018

  1. A body shape index and vascular structure and function in Spanish adults (MARK study) A cross-sectional study

    Medicine (United States), Vol. 97, Núm. 47

  2. A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study

    Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704

2017

  1. Adiposity measures and arterial stiffness in primary care: The MARK prospective observational study

    BMJ Open, Vol. 7, Núm. 9

  2. Glycemic markers and relation with arterial stiffness in Caucasian subjects of the MARK study

    PLoS ONE, Vol. 12, Núm. 4

2016

  1. Association between markers of glycemia and carotid intima-media thickness: The MARK study

    BMC Cardiovascular Disorders, Vol. 16, Núm. 1

  2. Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: A cross-sectional trial

    Cardiovascular Diabetology, Vol. 15, Núm. 1

  3. Vascular structure and function and their relationship with health-related quality of life in the MARK study

    BMC Cardiovascular Disorders, Vol. 16, Núm. 1

2015

  1. Leukocyte subtype counts and its association with vascular structure and function in adults with intermediate cardiovascular risk. MARK study

    PLoS ONE, Vol. 10, Núm. 4

  2. The association between the cardio-ankle vascular index and other parameters of vascular structure and function in Caucasian adults: MARK study

    Journal of Atherosclerosis and Thrombosis, Vol. 22, Núm. 9, pp. 901-911

2011

  1. Improving interMediAte Risk management. MARK study

    BMC Cardiovascular Disorders, Vol. 11